NASDAQ:DOMH Dominari (DOMH) Stock Price, News & Analysis $5.85 +0.17 (+2.99%) As of 09/5/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Dominari Stock (NASDAQ:DOMH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Dominari alerts:Sign Up Key Stats Today's Range$5.61▼$5.9950-Day Range$4.41▼$6.6752-Week Range$0.83▼$13.58Volume114,570 shsAverage Volume390,466 shsMarket Capitalization$90.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York. Read More Dominari Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreDOMH MarketRank™: Dominari scored higher than 12% of companies evaluated by MarketBeat, and ranked 869th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Dominari. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Dominari is -2.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dominari is -2.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDominari has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Dominari's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted8.64% of the float of Dominari has been sold short.Short Interest Ratio / Days to CoverDominari has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dominari has recently decreased by 13.91%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDominari does not currently pay a dividend.Dividend GrowthDominari does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.64% of the float of Dominari has been sold short.Short Interest Ratio / Days to CoverDominari has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dominari has recently decreased by 13.91%, indicating that investor sentiment is improving significantly. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows3 people have added Dominari to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Dominari insiders have not sold or bought any company stock.Percentage Held by Insiders32.98% of the stock of Dominari is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.48% of the stock of Dominari is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Dominari's insider trading history. Receive DOMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOMH Stock News HeadlinesDominari Holdings Files $2 Billion Shelf to Support Strategic ExpansionAugust 28, 2025 | prnewswire.comDominari Holdings Forms Crypto Advisory Board to Support Strategic ExpansionAugust 26, 2025 | prnewswire.comCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation. | SmartAsset (Ad)Dominari Holdings Announces Record Date for Cash DividendAugust 22, 2025 | prnewswire.comDominari Holdings Featured in The Wall Street JournalAugust 19, 2025 | prnewswire.comDominari Marks Inflection Point with Second Quarter 2025 Financial ResultsAugust 12, 2025 | prnewswire.comDominari Securities Serves as Exclusive Placement Agent to SRM Entertainment on a $100 Million Equity InvestmentJune 17, 2025 | prnewswire.comDominari Holdings Set to Join Russell Microcap® IndexMay 28, 2025 | prnewswire.comSee More Headlines DOMH Stock Analysis - Frequently Asked Questions How have DOMH shares performed this year? Dominari's stock was trading at $0.9844 at the start of the year. Since then, DOMH stock has increased by 494.3% and is now trading at $5.85. How were Dominari's earnings last quarter? Dominari Holdings Inc. (NASDAQ:DOMH) posted its quarterly earnings data on Monday, August, 11th. The company reported ($1.02) earnings per share (EPS) for the quarter. The firm earned $34.10 million during the quarter. Dominari had a negative trailing twelve-month return on equity of 94.32% and a negative net margin of 36.01%. Who are Dominari's major shareholders? Top institutional shareholders of Dominari include Connective Capital Management LLC (1.82%), Geode Capital Management LLC (0.45%), Jane Street Group LLC (0.19%) and Magnus Financial Group LLC (0.17%). Insiders that own company stock include Christopher Franklin Devall and Kyle Michael Wool. View institutional ownership trends. How do I buy shares of Dominari? Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Dominari own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dominari investors own include Avino Silver & Gold Mines (ASM), Crescent Point Energy (CPG), Infinera (INFN), Kroger (KR), KraneShares CSI China Internet ETF (KWEB) and MSP Recovery (LIFW). Company Calendar Last Earnings8/11/2025Record date for 9/26 Dividend9/03/2025Ex-Dividend for 9/26 Dividend9/03/2025Today9/05/2025Dividend Payable9/26/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryBiotechnology Current SymbolNASDAQ:DOMH Previous SymbolNASDAQ:DOMH CIK12239 WebN/A Phone(112) 745-1374Fax703-992-9348Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.70 million Net Margins-36.01% Pretax Margin-34.03% Return on Equity-94.32% Return on Assets-78.21% Debt Debt-to-Equity RatioN/A Current Ratio3.65 Quick Ratio3.65 Sales & Book Value Annual Sales$18.15 million Price / Sales5.01 Cash FlowN/A Price / Cash FlowN/A Book Value$5.71 per share Price / Book1.02Miscellaneous Outstanding Shares15,540,000Free Float10,418,000Market Cap$90.91 million OptionableNot Optionable Beta0.75 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:DOMH) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dominari Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dominari With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.